Finerenone
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1052 publications
Letter by Nie and Xiong Regarding Article, "Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF".
Journal: Circulation. Heart failure
Published: June 24, 2026
Response by McMurray to Letter Regarding Article, "Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF".
Journal: Circulation. Heart failure
Published: June 24, 2026
Nonsteroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Mechanistic Basis, Clinical Evidence, and Therapeutic Integration.
Journal: Drugs and drug candidates
Published: June 17, 2026
Which aldosterone antagonist? Choosing between sprionolactone and the novel drug finerenone
Journal: Nederlands tijdschrift voor geneeskunde
Published: June 15, 2026
Finerenone Prescriptions in the United States (2021-2024) by Physician Specialty: Analysis of Use and Potential in the Cardiovascular-Kidney-Metabolic Space.
Journal: Journal of the American Heart Association
Published: June 09, 2026
Finerenone in Persons with Chronic Kidney Disease without Diabetes.
Journal: The New England journal of medicine
Published: June 05, 2026
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: Research Summary.
Journal: JAMA
Published: June 05, 2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: June 05, 2026
Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
Journal: The New England journal of medicine
Published: June 03, 2026
Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
Journal: The New England journal of medicine
Published: June 03, 2026
Last Updated: 06/30/2026